1.Sun Y, Zhuang Y, Cheng K, Wei Y, Li M, Xuan J, Zheng S, Guo M, Zhang Z. YTHDF2-orchestrated m6A methylation of BECN1 induces Scoparone-mediated hepatic stellate cell ferroptosis to attenuate liver fibrosis. Phytomedicine. 2026; 153:157912.

2.Li Y, Shen M, Li M, Qiu Y, Wang Y, Shao J, Xuan J, Zheng S, Zhang Z. m6A methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma. Chem Biol Interact. 2026; 427:111950.

3.Li M, Sun Y, Wei Y, Li Y, Shao JJ, Guo M, Zheng S, Zhang Z. Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein. Free Radic Biol Med. 2025; 231:120-135.

4.Sun YQ, Wu Y, Li MR, Wei YY, Guo M, Zhang ZL. Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. World J Gastroenterol. 2024; 30:4660-4668.

5.Guo M, Zhuang Y, Wu Y, Zhang C, Cheng X, Xu D, Zhang Z. The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease. Hepatol Commun. 2024; 8: e0396.

6.Zhang Z, Guo M, Li Y, Shen M, Kong D, Shao J, Ding H, Tan S, Chen A, Zhang F, Zheng S. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020; 16: 1482-1505.

7.Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J, Tan S, Wang S, Chen A, Cao P, Zheng S. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biology. 2020; 36: 101619.

8.Zhang Z, Yao Z, Wang L, Ding H, Shao J, Chen A, Zhang F, Zheng S. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells. Autophagy. 2018; 14: 2083-2103.

9.Zhang Z, Yao Z, Zhao S, Shao J, Chen A, Zhang F, Zheng S. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis, Cell Death Disease. 2017; 8: e2886.

10.Zhang Z, Guo M, Zhao S, Shao J, Zheng S. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis. Free Radic Biol Med. 2016; 101:272-283.

1.国家自然科学基金面上项目（82474164），中药活性成分滨蒿内酯上调ZDHHC12介导的BECN1棕榈酰化修饰促进肝星状细胞铁死亡与胞葬改善肝纤维化的作用机制研究，2025/01 至 2028/12，主持，49万，在研

2.国家自然科学基金青年项目（82000572），m6A甲基化识别蛋白YTHDF1调控自噬通路关键基因BECN1介导肝星状细胞铁死亡在改善肝纤维化病变损伤中的作用及分子机制研究，2021/01 至 2023/12，主持，24万元，结题

3.中华中医药学会青年托举人才项目（2022-QNRC2-B15,），双氢青蒿素调控肝星状细胞铁死亡抗肝纤维化机制研究，2022/01 至 2024/12，主持，3万元，结题

4.江苏省自然科学基金项目（BK20200840）, m6A甲基化修饰通过自噬通路调控肝星状细胞铁死亡在肝纤维化发病机制中的作用和干预靶点研究，2021/01 至 2023/12，主持，20万元，结题

5.江苏省高等学校自然科学研究面上项目（20KJB310003）, BECN1 m6A修饰调控 HSC铁死亡改善肝纤维化的作用机制研究, 2021/06 至 2022/07，主持，5万元，结题

6.南京中医药大学自然科学基金项目（NZY82000572），m6A甲基化识别蛋白YTHDF1调控自噬通路关键基因BECN1介导肝星状细胞铁死亡在改善肝纤维化病变损伤中的作用及分子机制研究，2021/01 至 2023/12，主持，24万元，结题

7.南京中医药大学自然科学基金项目（XZR2020040），厚朴通过PI3K/Akt/mTOR和AMPK信号通路Crosstalk调控自噬抑制肿瘤转移机制研究，2021/01 至 2023/12，主持，8万元，结题

8.国家自然科学基金面上项目（82173874）, 白术内酯III通过孤核受体Nur77调控肝细胞酮体生成抗肝纤维化的作用与机制, 2022/01至2025/12, 参与，55万元，结题

9.国家自然科学基金面上项目（82074067）, 基于SUMO化修饰调控的中药石蝉草裂木脂素抗KRAS突变型肿瘤的作用机制研究, 2021/01至2024/12, 参与，55万元，结题

10.国家自然科学基金面上项目（82073914）, 双氢青蒿素通过核受体Rev-Erbα调控肝星状细胞脂噬与铁死亡的抗肝纤维化机制研究, 2021/01至2024/12, 参与，55万元，结题

1.Sun Y, Zhuang Y, Cheng K, Wei Y, Li M, Xuan J, Zheng S, Guo M, Zhang Z. YTHDF2-orchestrated m6A methylation of BECN1 induces Scoparone-mediated hepatic stellate cell ferroptosis to attenuate liver fibrosis. Phytomedicine. 2026; 153:157912.

2.Li Y, Shen M, Li M, Qiu Y, Wang Y, Shao J, Xuan J, Zheng S, Zhang Z. m6A methylation dependent autophagy activation is required for anti-tumor effects of artesunate through ferroptosis in hepatocellular carcinoma. Chem Biol Interact. 2026; 427:111950.

3.Li M, Sun Y, Wei Y, Li Y, Shao JJ, Guo M, Zheng S, Zhang Z. Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein. Free Radic Biol Med. 2025; 231:120-135.

4.Sun YQ, Wu Y, Li MR, Wei YY, Guo M, Zhang ZL. Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function. World J Gastroenterol. 2024; 30:4660-4668.

5.Guo M, Zhuang Y, Wu Y, Zhang C, Cheng X, Xu D, Zhang Z. The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease. Hepatol Commun. 2024; 8: e0396.

6.Zhang Z, Guo M, Li Y, Shen M, Kong D, Shao J, Ding H, Tan S, Chen A, Zhang F, Zheng S. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020; 16: 1482-1505.

7.Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J, Tan S, Wang S, Chen A, Cao P, Zheng S. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biology. 2020; 36: 101619.

8.Zhang Z, Yao Z, Wang L, Ding H, Shao J, Chen A, Zhang F, Zheng S. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells. Autophagy. 2018; 14: 2083-2103.

9.Zhang Z, Yao Z, Zhao S, Shao J, Chen A, Zhang F, Zheng S. Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis, Cell Death Disease. 2017; 8: e2886.

10.Zhang Z, Guo M, Zhao S, Shao J, Zheng S. ROS-JNK1/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis. Free Radic Biol Med. 2016; 101:272-283.

1.2023年中华中医药学会科学技术奖二等奖（排名第五）

2.2023年江苏中医药科学技术奖二等奖（排名第五）

3.2022年度第十七届“挑战杯”大学生课外学术作品竞赛全国一等奖（指导教师排名第一）

4.2021年度全国中医药优秀博士论文提名奖（排名第一）

5.2020年度江苏省优秀博士论文（排名第一）

6.2020年度江苏省研究生教育改革成果优秀奖（排名第五）

1. 国家发明专利：张自力; 王娴; 邵江娟; 张峰; 谭善忠; 郑仕中; 一种治疗肝纤维化的中药复方制剂及其制备方法与应用, 2020-11-25, 专利号CN202011339886.4

2. 研究生教材：《血管生成研究方法学》，人民卫生出版社，2014年，编委